Precigen IncNASDAQ:PGEN
- LAST PRICE1.5800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.5100/ 4
- Ask / Lots1.5700/ 60
- Open / Previous Close1.5000 / 1.5800
- Day Range
- 52 Week Range
- Volume1,842,516
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PGEN |
|---|---|---|
| 09:32 ET | 10378 | 1.515 |
| 09:36 ET | 3738 | 1.52 |
| 09:38 ET | 100 | 1.525 |
| 09:39 ET | 1200 | 1.53 |
| 09:41 ET | 200 | 1.525 |
| 09:43 ET | 1276 | 1.53 |
| 09:45 ET | 2100 | 1.535 |
| 09:48 ET | 2100 | 1.53 |
| 09:50 ET | 2330 | 1.53 |
| 09:56 ET | 1700 | 1.5201 |
| 09:57 ET | 100 | 1.525 |
| 09:59 ET | 200 | 1.525 |
| 10:01 ET | 100 | 1.52 |
| 10:03 ET | 300 | 1.525 |
| 10:08 ET | 100 | 1.52 |
| 10:10 ET | 200 | 1.53 |
| 10:15 ET | 200 | 1.53 |
| 10:17 ET | 300 | 1.52 |
| 10:19 ET | 1422 | 1.525 |
| 10:21 ET | 3402 | 1.52 |
| 10:24 ET | 7678 | 1.53 |
| 10:26 ET | 3521 | 1.52 |
| 10:28 ET | 1883 | 1.52 |
| 10:30 ET | 2495 | 1.515 |
| 10:32 ET | 3103 | 1.505 |
| 10:33 ET | 1900 | 1.5 |
| 10:35 ET | 13400 | 1.5 |
| 10:37 ET | 4500 | 1.505 |
| 10:39 ET | 3679 | 1.5 |
| 10:42 ET | 1600 | 1.5 |
| 10:44 ET | 1300 | 1.5 |
| 10:48 ET | 1820 | 1.5 |
| 10:50 ET | 6000 | 1.5092 |
| 10:51 ET | 2100 | 1.5 |
| 10:53 ET | 500 | 1.5088 |
| 10:55 ET | 2386 | 1.505 |
| 10:57 ET | 12319 | 1.49 |
| 11:00 ET | 5000 | 1.49 |
| 11:02 ET | 38256 | 1.49 |
| 11:04 ET | 6200 | 1.4811 |
| 11:06 ET | 433 | 1.49 |
| 11:08 ET | 1389 | 1.49 |
| 11:09 ET | 22500 | 1.49 |
| 11:11 ET | 2900 | 1.49 |
| 11:13 ET | 5000 | 1.4807 |
| 11:15 ET | 6479 | 1.4999 |
| 11:18 ET | 629 | 1.49 |
| 11:20 ET | 1973 | 1.49 |
| 11:22 ET | 900 | 1.495 |
| 11:24 ET | 2600 | 1.49 |
| 11:26 ET | 800 | 1.48 |
| 11:27 ET | 200 | 1.485 |
| 11:29 ET | 800 | 1.48 |
| 11:31 ET | 38123 | 1.4701 |
| 11:33 ET | 7909 | 1.475 |
| 11:36 ET | 8709 | 1.48 |
| 11:40 ET | 1100 | 1.48 |
| 11:42 ET | 6000 | 1.4709 |
| 11:44 ET | 1370 | 1.475 |
| 11:45 ET | 12001 | 1.47 |
| 11:47 ET | 500 | 1.479 |
| 11:49 ET | 4200 | 1.47 |
| 11:54 ET | 6395 | 1.48 |
| 11:56 ET | 100 | 1.485 |
| 12:00 ET | 3000 | 1.4815 |
| 12:02 ET | 100 | 1.485 |
| 12:03 ET | 8000 | 1.49 |
| 12:05 ET | 250 | 1.49 |
| 12:07 ET | 100 | 1.49 |
| 12:09 ET | 100 | 1.49 |
| 12:18 ET | 150 | 1.4899 |
| 12:20 ET | 2100 | 1.4892 |
| 12:21 ET | 3600 | 1.48 |
| 12:23 ET | 1998 | 1.4846 |
| 12:27 ET | 100 | 1.48 |
| 12:30 ET | 4450 | 1.4899 |
| 12:32 ET | 5249 | 1.5 |
| 12:34 ET | 3108 | 1.505 |
| 12:36 ET | 6375 | 1.51 |
| 12:38 ET | 7200 | 1.51 |
| 12:41 ET | 12073 | 1.5 |
| 12:43 ET | 200 | 1.505 |
| 12:48 ET | 100 | 1.5 |
| 12:52 ET | 300 | 1.5 |
| 12:56 ET | 1954 | 1.51 |
| 12:57 ET | 100 | 1.51 |
| 12:59 ET | 100 | 1.505 |
| 01:01 ET | 400 | 1.51 |
| 01:06 ET | 101 | 1.5 |
| 01:08 ET | 200 | 1.505 |
| 01:10 ET | 100 | 1.51 |
| 01:12 ET | 3545 | 1.51 |
| 01:17 ET | 100 | 1.52 |
| 01:19 ET | 100 | 1.52 |
| 01:21 ET | 1100 | 1.51 |
| 01:24 ET | 1500 | 1.515 |
| 01:26 ET | 11453 | 1.5 |
| 01:28 ET | 1300 | 1.5 |
| 01:30 ET | 1100 | 1.5 |
| 01:32 ET | 1100 | 1.5 |
| 01:33 ET | 4535 | 1.5 |
| 01:35 ET | 3000 | 1.5 |
| 01:37 ET | 5019 | 1.5 |
| 01:39 ET | 3110 | 1.49 |
| 01:42 ET | 100 | 1.49 |
| 01:44 ET | 100 | 1.495 |
| 01:46 ET | 100 | 1.49 |
| 01:48 ET | 400 | 1.495 |
| 01:50 ET | 1400 | 1.5 |
| 01:51 ET | 400 | 1.49 |
| 01:53 ET | 592 | 1.49 |
| 01:55 ET | 500 | 1.495 |
| 01:57 ET | 100 | 1.49 |
| 02:00 ET | 592 | 1.5 |
| 02:02 ET | 500 | 1.49 |
| 02:04 ET | 300 | 1.495 |
| 02:06 ET | 300 | 1.49 |
| 02:08 ET | 600 | 1.49 |
| 02:09 ET | 800 | 1.49 |
| 02:11 ET | 100 | 1.49 |
| 02:13 ET | 4675 | 1.5 |
| 02:15 ET | 100 | 1.505 |
| 02:20 ET | 100 | 1.505 |
| 02:26 ET | 200 | 1.505 |
| 02:27 ET | 100 | 1.5 |
| 02:29 ET | 934 | 1.5 |
| 02:31 ET | 100 | 1.505 |
| 02:33 ET | 10500 | 1.51 |
| 02:40 ET | 300 | 1.51 |
| 02:42 ET | 100 | 1.51 |
| 02:44 ET | 600 | 1.51 |
| 02:45 ET | 200 | 1.51 |
| 02:49 ET | 200 | 1.51 |
| 02:51 ET | 5480 | 1.5 |
| 02:54 ET | 1200 | 1.5 |
| 02:56 ET | 1300 | 1.5001 |
| 02:58 ET | 8767 | 1.5 |
| 03:00 ET | 10000 | 1.5 |
| 03:02 ET | 17745 | 1.505 |
| 03:03 ET | 100 | 1.5 |
| 03:05 ET | 537 | 1.505 |
| 03:07 ET | 300 | 1.505 |
| 03:09 ET | 400 | 1.51 |
| 03:12 ET | 300 | 1.5 |
| 03:14 ET | 700 | 1.5 |
| 03:16 ET | 300 | 1.505 |
| 03:18 ET | 500 | 1.505 |
| 03:20 ET | 100 | 1.505 |
| 03:21 ET | 7687 | 1.51 |
| 03:23 ET | 4952 | 1.51 |
| 03:25 ET | 644 | 1.51 |
| 03:27 ET | 200 | 1.5 |
| 03:30 ET | 1900 | 1.505 |
| 03:34 ET | 100 | 1.505 |
| 03:36 ET | 300 | 1.505 |
| 03:38 ET | 200 | 1.505 |
| 03:43 ET | 300 | 1.505 |
| 03:45 ET | 635 | 1.505 |
| 03:48 ET | 246 | 1.51 |
| 03:50 ET | 100 | 1.51 |
| 03:52 ET | 167614 | 1.58 |
| 03:54 ET | 42484 | 1.585 |
| 03:56 ET | 60087 | 1.58 |
| 03:57 ET | 12197 | 1.585 |
| 03:59 ET | 19266 | 1.58 |
Jun 4, 2024
DJ Precigen Price Target Maintained With a $14.00/Share by JMP Securities, from 8:42AM ET on Tuesday Jun 04, 2024 by Dow Jones
8:42AM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
DJ Precigen Price Target Maintained With a $6.00/Share by HC Wainwright & Co., from 12:30PM ET on Monday Jun 03, 2024 by Dow Jones
12:30PM ET on Monday Jun 03, 2024 by Dow JonesDJ Precigen Is Maintained at Buy by Stifel, from 12:30PM ET on Monday Jun 03, 2024 by Dow Jones
12:30PM ET on Monday Jun 03, 2024 by Dow JonesPrecigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response, from 9:30AM ET on Monday Jun 03, 2024 by Dow Jones
9:30AM ET on Monday Jun 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Precigen Inc | 398.8M | -4.1x | --- |
Jasper Therapeutics Inc | 342.4M | -4.1x | --- |
Verrica Pharmaceuticals Inc | 309.2M | -4.2x | --- |
Bio Essence Corp | 282.4M | -330.4x | --- |
ASP Isotopes Inc | 158.4M | -5.7x | --- |
Pliant Therapeutics Inc | 648.5M | -3.8x | --- |
Company Information
Precigen, Inc. is a dedicated discovery and clinical-stage biopharmaceutical company advancing gene and cell therapies. The Company’s proprietary technology platforms develops product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company operates through two segments: Biopharmaceuticals and Exemplar. Biopharmaceuticals segment is primarily comprised of the Company's legal entities of Precigen and ActoBio, as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. Exemplar segment is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar (Exemplar), its wholly owned subsidiary focused on developing research models and services for healthcare research applications.
Contact Information
- Headquarters
- 20374 SENECA MEADOWS PARKWAYGERMANTOWN, MD, United States 20876
- Phone
- 301-556-9900
- Fax
- ---
Executives
- Executive Chairman of the Board
- Randal Kirk
- President, Chief Executive Officer, Director, President of PGEN Therapeutics, Inc.
- Helen Sabzevari
- Chief Financial Officer
- Harry Thomasian
- Chief Operating Officer
- Rutul Shah
- Senior Vice President - Intellectual Property Affairs
- Jeffrey Perez
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $398.8M |
|---|---|
Revenue (TTM) | $5.4M |
Shares Outstanding | 252.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.73 |
EPS | $-0.39 |
Book Value | $0.48 |
P/E Ratio | -4.1x |
Price/Sales (TTM) | 73.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,851.17% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
